Comparison Neumora Therapeutics (NMRA) with Competitors
Neumora Therapeutics (NMRA) industry is Biotechnology.
Debt-to-Equity
NMRA159.82%
Industry28.27%
Upside+465.38%
Free Cash Flow Yield
NMRA-65.97%
Industry-1.75%
Upside-64.23%
P/E
NMRA-1.17
Industry-20.52
Upside+1934.90%
P/B
NMRA4.14
Industry5.15
Upside-19.52%